Beijing Tong Ren Tang Chinese Medicine Company Limited announced group unaudited earnings results for the third quarter and nine months ended September 30, 2016. For the quarter, the company reported revenue of HKD 266,292,000 compared with HKD 231,253,000 for the same period a year ago. Operating profit was HKD 132,371,000 compared with HKD 109,860,000 for the same period a year ago. Profit before income tax was HKD 133,626,000 compared with HKD 110,219,000 for the same period a year ago. Profit attributable to owners of the company was HKD 105,280,000 compared with HKD 84,098,000 for the same period a year ago. Basic and diluted earnings per share was HKD 0.13 compared with HKD 0.10 for the same period a year ago. During the nine months ended 30 September 2016, the revenue of the Group was HKD 808.2 million compared with HKD 715.4 million for the same period a year ago, representing an increase of 13.0% as compared to the same period last year. The profit attributable to owners of the company was HKD 333.8 million compared with HKD 257.2 million for the same period a year ago, representing an increase of 29.8% as compared to the same period last year. For the nine months, the company reported operating profit was HKD 418,526,000 compared with HKD 328,760,000 for the same period a year ago. Profit before income tax was HKD 422,322,000 compared with HKD 334,026,000 for the same period a year ago. Basic and diluted earnings per share was HKD 0.40 compared with HKD 0.31 for the same period a year ago.